Einzeltreffer — DigiBib

This study aimed to report the most current data on the incidence and disability-adjusted life years (DALY) associated with osteoarthritis in China from 1990 to 2019. Publicly available modelled data from Global Burden of Disease Study (GBD) 2019 were used. The incidence and DALY, due to osteoarthritis in China, stratified by sex, trends of associated risk factors, assess the age, period, and cohort effects on the long-term trends of osteoarthritis incidence and DALY in China from 1990 to 2019. We found that the age-standardized incidence and DALY rates of osteoarthritis in China are higher than the average levels in Asia, Africa, and Oceania. In 2019, the number of cases of osteoarthritis in China was 10,681,311, an increase of 132.66% compared with 1990. the DALY of osteoarthritis in China was 4,724,885 person-years, which was 159.70% higher than that in 1990. In 2019, the incidence and DALY rates of osteoarthritis in China was 750.96/100,000,332.19/100,000. High body-mass as risk factors for osteoarthritis DALY with the population attributable proportion (PAF) increasing steadily from 1990 to 2019. The incidence and DALY rates of three types of osteoarthritis from high to low are osteoarthritis knee, osteoarthritis hand, and osteoarthritis hip. Age-period-cohort model showed that the incidence rate of osteoarthritis in China shows a trend of increasing first and then decreasing with age; concurrently, the DALY rate of osteoarthritis in China increased with age. For the period effect, we found that the period rate ratio (RR) of osteoarthritis incidence and DALY rates kept increasing in the cohort born before 2005-2009, and then, it was gradually reduced by year of birth in the cohort born after 2005-2009. As for cohort effect, the cohort RR of incidence rate of osteoarthritis almost has no change, while the cohort RR of DALY rate of osteoarthritis kept increasing from 1990 to 2019. The burden and impact of osteoarthritis in China are substantial and are increasing. Adopting suitable control and preventive community measures to reduce modifiable risk factors is needed to reduce the current and future burden of osteoarthritis in China. Key Points • This paper analyzes the disease burden of osteoarthritis in China for the first time and discusses the influence on the disease burden of osteoarthritis from the perspectives of age, period, and cohort.

Titel:	Burden of osteoarthritis in China, 1990-2019: findings from the Global Burden of Disease Study 2019.
Autor/in / Beteiligte Person:	Li, H ; Kong, W ; Liang, Y ; Sun, H
Link:	Full Text Finder (Volltext)
Zeitschrift:	Clinical rheumatology, Jg. 43 (2024-03-01), Heft 3, S. 1189-1197
Veröffentlichung:	<2008->: Heidelberg : Springer ; <i>Original Publication</i>: Brussels : Acta Medica Belgica, [1982-, 2024
Medientyp:	academicJournal
ISSN:	1434-9949 (electronic)
DOI:	10.1007/s10067-024-06885-9
Schlagwort:	Humans Quality-Adjusted Life Years Cost of Illness China epidemiology Incidence Global Burden of Disease Osteoarthritis epidemiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Journal Article Language: English [Clin Rheumatol] 2024 Mar; Vol. 43 (3), pp. 1189-1197. <i>Date of Electronic Publication: </i>2024 Jan 30. MeSH Terms: Global Burden of Disease* ; Osteoarthritis* / epidemiology ; Humans ; Quality-Adjusted Life Years ; Cost of Illness ; China / epidemiology ; Incidence References: Szponder T, Latalski M, Danielewicz A, Krać K, Kozera A, Drzewiecka B et al (2022) Osteoarthritis: pathogenesis, animal models, and new regenerative therapies. J Clin Med 12(1):5. (PMID: 10.3390/jcm12010005366148069821671) ; Runge N, Aina A, May S (2022) The benefits of adding manual therapy to exercise therapy for improving pain and function in patients with knee or hip osteoarthritis: a systematic review with meta-analysis. J Orthop Sports Phys Ther 52(10):675. (PMID: 10.2519/jospt.2022.1106235881705) ; Petersen KK, Drewes AM, Olesen AE, Ammitzbøll N, Bertoli D, Brock C et al (2022) The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-a randomized, double-blind, placebo-controlled, crossover study. Eur J Pain 26(8):1650–1664. (PMID: 10.1002/ejp.1988356383179541875) ; Zheng X, Wang YY, Jin WY, Huang CR, Yan ZW, Peng DL et al (2023) Intraindividual variance of lower limb rotation in patients with bilateral knee osteoarthritis. Front Surg 10:964160. (PMID: 10.3389/fsurg.2023.9641603693665010016351) ; Wang J, Ushirozako H, Yamato Y, Hasegawa T, Yoshida G, Banno T et al (2023) Why does knee flexion in the standing position occur? Spinal deformity or knee osteoarthritis. J Orthop Surg (Hong Kong) 31(1):10225536231169576. (PMID: 10.1177/1022553623116957537039267) ; Bannuru RR, Osani MC, Vaysbrot EE, Arden NK, Bennell K, Bierma-Zeinstra SMA et al (2019) OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage 27(11):1578–1589. (PMID: 10.1016/j.joca.2019.06.01131278997) ; GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396(10258):1204–1222. (PMID: 10.1016/S0140-6736(20)30925-9) ; Chen X, Tang H, Lin J, Zeng R (2023) Temporal trends in the disease burden of osteoarthritis from 1990 to 2019, and projections until 2030. PLoS One 18(7):e0288561. (PMID: 10.1371/journal.pone.02885613748694910365297) ; Richard MJ, Driban JB, McAlindon TE (2023) Pharmaceutical treatment of osteoarthritis. Osteoarthritis Cartilage 31(4):458–466. (PMID: 10.1016/j.joca.2022.11.00536414224) ; Murray CJL (2022) The Global Burden of Disease study at 30 years. Nat Med 28(10):2019–2026. (PMID: 10.1038/s41591-022-01990-136216939) ; Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16(4):494–502. (PMID: 10.1136/ard.16.4.494134986041006995) ; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392(10159):1789–1858. (PMID: 10.1016/S0140-6736(18)32279-7) ; GBD 2019 Cancer Risk Factors Collaborators (2022) The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 400(10352):563–591. (PMID: 10.1016/S0140-6736(22)01438-6) ; Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA, Hoy D, Ashrafi-Asgarabad A, Sepidarkish M, Almasi-Hashiani A, Collins G, Kaufman J, Qorbani M, Moradi-Lakeh M, Woolf AD, Guillemin F, March L, Cross M (2020) Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis 79(6):819–828. (PMID: 10.1136/annrheumdis-2019-21651532398285) ; Wei D, Xiao W, Zhou L, Guo J, Lu W, Wang Y (2022) Age-period-cohort analysis of ischemic heart disease morbidity and mortality in China, 1990–2019. Circ J 86(9):1437–1443. (PMID: 10.1253/circj.CJ-21-074935569970) ; Kumar A, Palit P, Thomas S, Gupta G, Ghosh P, Goswami RP et al (2021) Osteoarthritis: prognosis and emerging therapeutic approach for disease management. Drug Dev Res 82(1):49–58. (PMID: 10.1002/ddr.2174132931079) ; Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y et al (2022) Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 2019. Arthritis Rheumatol 74(7):1172–1183. (PMID: 10.1002/art.42089352339759543105) ; Safiri S, Kolahi AA, Smith E, Hill C, Bettampadi D, Mansournia MA et al (2020) Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the Global Burden of Disease Study 2017. Ann Rheum Dis 79(6):819–828. (PMID: 10.1136/annrheumdis-2019-21651532398285) ; Wan J, Qian X, He Z, Zhu Z, Cheng P, Chen A (2022) Epidemiological trends of hand osteoarthritis from 1990 to 2019: estimates from the 2019 Global Burden of Disease study. Front Med (Lausanne) 9:922321. (PMID: 10.3389/fmed.2022.92232136579153) ; Zhakhina G, Gusmanov A, Sakko Y, Yerdessov S, Semenova Y, Saginova D et al (2023) The regional burden and disability-adjusted life years of knee osteoarthritis in Kazakhstan 2014–2020. Biomedicines 11(1):216. (PMID: 10.3390/biomedicines11010216366727249856102) ; Hoveidaei AH, Nakhostin-Ansari A, Hosseini-Asl SH, Khonji MS, Razavi SE, Darijani SR et al (2023) Increasing burden of hip osteoarthritis in the Middle East and North Africa (MENA): an epidemiological analysis from 1990 to 2019. Arch Orthop Trauma Surg 143(6):3563–3573. (PMID: 10.1007/s00402-022-04582-336038782) ; Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M et al (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. (PMID: 10.1136/annrheumdis-2013-20476324553908) ; Kiadaliri AA, Lohmander LS, Moradi-Lakeh M, Petersson IF, Englund M (2018) High and rising burden of hip and knee osteoarthritis in the Nordic region, 1990–2015. Acta Orthop 89(2):177–183. (PMID: 10.1080/17453674.2017.140479129160139) ; Constantino de Campos G, Mundi R, Whittington C, Toutounji MJ, Ngai W, Sheehan B (2020) Osteoarthritis, mobility-related comorbidities and mortality: an overview of meta-analyses. Ther Adv Musculoskelet Dis 12:1759720X20981219. (PMID: 10.1177/1759720X20981219334887867768583) ; Geusens PP, van den Bergh JP (2016) Osteoporosis and osteoarthritis: shared mechanisms and epidemiology. Curr Opin Rheumatol 28(2):97–103. (PMID: 10.1097/BOR.000000000000025626780427) ; Gregori D, Giacovelli G, Minto C, Barbetta B, Gualtieri F, Azzolina D et al (2018) Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: a systematic review and meta-analysis. JAMA 320(24):2564–2579. (PMID: 10.1001/jama.2018.19319305758816583519) ; Silverwood V, Blagojevic-Bucknall M, Jinks C, Jordan JL, Protheroe J, Jordan KP (2015) Current evidence on risk factors for knee osteoarthritis in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage 23(4):507–515. (PMID: 10.1016/j.joca.2014.11.01925447976) ; Whittaker JL, Runhaar J, Bierma-Zeinstra S, Roos EM (2021) A lifespan approach to osteoarthritis prevention. Osteoarthritis Cartilage 29(12):1638–1653. (PMID: 10.1016/j.joca.2021.06.01534560260) ; He Y, Li Z, Alexander PG, Ocasio-Nieves BD, Yocum L, Lin H et al (2020) Pathogenesis of osteoarthritis: risk factors, regulatory pathways in chondrocytes, and experimental models. Biology (Basel) 9(8):194. (PMID: 32751156) ; GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K et al (2017) Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med 377(1):13–27. (PMID: 10.1056/NEJMoa1614362) ; Sun X, Yan AF, Shi Z, Zhao B, Yan N, Li K et al (2022) Health consequences of obesity and projected future obesity health burden in China. Obesity (Silver Spring) 30(9):1724–1751. (PMID: 10.1002/oby.2347236000246) ; Havulinna AS (2014) Bayesian age-period-cohort models with versatile interactions and long-term predictions: mortality and population in Finland 1878–2050. Stat Med 33(5):845–856. (PMID: 10.1002/sim.595424105769) ; Scire CA, Manara M, Cimmino MA, Govoni M, Salaffi F, Punzi L et al (2013) Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther 15(5):R101. (PMID: 10.1186/ar4281240045773979095) ; Ho J, Mak CCH, Sharma V, To K, Khan W (2022) Mendelian randomization studies of lifestyle-related risk factors for osteoarthritis: a PRISMA review and meta-analysis. Int J Mol Sci 23(19):11906. (PMID: 10.3390/ijms231911906362332089570129) ; Wang Z, Guo E, Yang B, Xiao R, Lu F, You L et al (2021) Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer. Gynecol Oncol 163(2):358–363. (PMID: 10.1016/j.ygyno.2021.08.02934507827) ; Lu D, Ding X, Lu W (2022) Study on the Influencing factors of osteoarthritis in southern China. Emerg Med Int 2022:2482728. (PMID: 10.1155/2022/2482728361587659492436) ; Hong H, Chen L, Zhong Y, Yang Z, Li W, Song C et al (2023) Associations of homocysteine, folate, and Vitamin B12 with osteoarthritis: a mendelian randomization study. Nutrients 15(7):1636. (PMID: 10.3390/nu150716363704947610096814) ; Chen A, Chen Y, Rong X, You X, Wu D, Zhou X et al (2023) The application of exosomes in the early diagnosis and treatment of osteoarthritis. Front Pharmacol 14:1154135. (PMID: 10.3389/fphar.2023.11541353718826310175594) ; Roggio F, Petrigna L, Trovato B, Di Rosa M, Musumeci G (2023) The role of lubricin, irisin and exercise in the prevention and treatment of osteoarthritis. Int J Mol Sci 24(6):5126. (PMID: 10.3390/ijms240651263698219810049370) Contributed Indexing: Keywords: China; Disability-adjusted life years; Incidence; Osteoarthritis Entry Date(s): Date Created: 20240130 Date Completed: 20240220 Latest Revision: 20240223 Update Code: 20240223 PubMed Central ID: PMC10876716

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Burden of osteoarthritis in China, 1990-2019: findings from the Global Burden of Disease Study 2019.